American Heart Association Scientific Sessions
Anticoagulants and Antiplatelet Agents
Since the optimal duration of dual antiplatelet therapy remains uncertain, researchers of a recent study examined a 1-month course of DAPT compared with 6 to 12-months of therapy following drug-eluting-stent implantation.
This direct-acting oral anticoagulant may be superior to the current standard of care anticoagulant for patients with a bioprosthetic mitral valve. In a study presented at AHA Scientific Sessions 2020, researchers compared the 2 treatments’ safety and efficacy.
A reduction in cardiovascular events may be possible with the use of a new combination pill of blood-pressure- and cholesterol-lowering medications. In this trial, the researchers examined how this “polypill”, aspirin, and the 2 together impact the risk of cardiovascular disease events.
Health Care Disparities
The COVID-19 pandemic has further magnified the racial/ethnic disparities present in the US health care system. In a recent study, the researchers examined the relationship of racial/ethnic differences, treatment, and patient outcomes for those hospitalized with COVID-19.